Increased proportion of CD226 + CD14 + monocytes correlates with clinical features and laboratory parameters in patients with primary Sjögren's syndrome.

Ping Zhao,Wei Cheng,Cuiping Liu,Cheng Peng,Yu Shen,Yanhong Yang,Chao Sun,Xin Chang,Jian Wu

International journal of rheumatic diseases（2023）

引用 0|浏览7

暂无评分

摘要

Our study suggested that an increased CD226 proportion on CD14 + monocytes was associated with the clinical manifestations, disease activity, and prognosis of pSS patients. CD226+ CD14 + monocytes may present a potential target and a biomarker for the prognosis and therapy of pSS patients.

查看译文

关键词

CD226, co-stimulatory receptor, monocytes, primary Sjogren's syndrome

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要